StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Earnings

Bone Biologics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Bone Biologics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Bone Biologics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Bone Biologics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Bone Biologics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. News
  3. Update
  4. Update
  5. News
  6. News
  7. News
  8. News
  9. News
  10. Update
  11. News
  12. News
  13. News
  14. News
  15. News

See a number that looks wrong?